Target intelligence / Profile preview

Coccidia (subclass Coccidiasina)

Molecular classification
Other (subclass of protozoan parasites; NOT receptor, enzyme, transporter, etc.)
01

Overview

Coccidia are a large subclass of microscopic, spore-forming, single-celled protozoan parasites obligately living and reproducing within animal cells. They predominantly infect the cells lining the intestines of vertebrates and some invertebrates, causing the disease known as coccidiosis, which presents clinically with diarrhea, weight loss, and other gastrointestinal symptoms, particularly in young or immunocompromised hosts[1][3][5][7]. Key genera within Coccidia include *Eimeria*, *Isospora*, *Toxoplasma*, *Sarcocystis*, and *Neospora*. Their life cycles involve both free-living oocyst stages and intracellular sporozoite stages, with both sexual and asexual reproductive phases[3]. Treatment of infections is primarily with antiprotozoal drugs and coccidiostats, and diagnosis is commonly made by identification of oocysts in feces or through molecular methods[7][2][8]. Coccidia are considered important pathogens in veterinary and human medicine, but as a group of organisms, they are not considered a classical therapeutic "target" such as a molecule or receptor.

Other names
Coccidiasinacoccidium (singular)apicomplexan protozoa
02

Mechanism of action

Drugs inhibit growth and replication of intracellular protozoan parasites

03

Biological functions

Obligate intracellular parasitismInfection of intestinal tract in animalsLife cycle involving asexual and sexual reproductive stages
04

Disease associations

Infection (coccidiosis in animals and humans)Other (complications in immunocompromised or young hosts)
05

Safety considerations

Resistance to treatment in some speciesHost immune suppression may complicate therapy
06

Interacting drugs

Antiprotozoal agents (e.g., coccidiostats are used to decrease oocyst production and disease)
07

Biomarkers

Identification of oocysts in feces by flotation methods or PCR of parasite DNA

Beyond the preview

Go deeper on Coccidia (subclass Coccidiasina).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Coccidia (subclass Coccidiasina).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call